Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and candesartan cilexetil

phorbol 12,13-dibutyrate has been researched along with candesartan cilexetil in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikehara, K; Inokuchi, T; Kuboki, K; Tada, H1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and candesartan cilexetil

ArticleYear
Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels.
    Diabetes research and clinical practice, 2003, Volume: 59, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Collagen Type IV; Culture Media; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Glomerular Mesangium; Glucose; Humans; Indoles; Maleimides; Phorbol 12,13-Dibutyrate; Protein Kinase C; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasoconstrictor Agents

2003